Tripterygium wilfordii tablets in the treatment of active ankylosing spondylitis: a randomized double-blind, placebo-controlled clinical trial.
Phase of Trial: Phase IV
Latest Information Update: 24 Jul 2014
At a glance
- Drugs Tripterygium wilfordii Hook F (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 21 May 2012 Planned end date changed from 1 Dec 2013 to 1 Jan 2013 as reported by Chinese Clinical Trial Register.
- 12 Mar 2011 New trial record